diff --git a/analysis/README.md b/analysis/README.md
index b22123d69b532680ffe5dccec7219985dbfe71e8..d522ac96c670cfd2f9e0e71c0614fd93a82ae2d1 100644
--- a/analysis/README.md
+++ b/analysis/README.md
@@ -2,10 +2,10 @@
 
 ## Repository content
 
-| NAME | DESCRIPTION |
-|-----------------------|------------------------ -------------------------------------------------- ---------------|
-| [figures]() | Directory with the figures generated as a result of the analysis|
-| files() | Directory with the intermediate files used during the analysis |
-| results() | Directory with the files generated as a result of the analysis |
-|[schizophrenia]() | Directory with the Jupyter Notebooks and Python scripts employed to study drug repusposing candidates for schizophrenia |
-| [total diseases analysis.ipynb]() | Jupyter Notebook used to analyze the disease module size and the proximity disease-drug for 495 diseases as a previous step to obtain the proximity distribution files (in results) that will be used in the analysis carried out for schizophrenia  |
+| NAME                  | DESCRIPTION                                                                                     |
+|-----------------------|-------------------------------------------------------------------------------------------------|
+| [figures]()           | Directory with the figures generated as a result of the analysis                                |
+| [files]()             | Directory with the intermediate files used during the analysis                                  |
+| [results]()           | Directory with the files generated as a result of the analysis                                  |
+| [schizophrenia]()    | Directory with the Jupyter Notebooks and Python scripts employed to study drug repurposing candidates for schizophrenia |
+| [total diseases analysis.ipynb]() | Jupyter Notebook used to analyze the disease module size and the proximity disease-drug for 495 diseases as a previous step to obtain the proximity distribution files (in results) that will be used in the analysis carried out for schizophrenia |